Triptolide-Mediated Apoptosis by Suppression of Focal Adhesion Kinase through Extrinsic and Intrinsic Pathways in

Haw-Young Kwon1, Kyoung-Sook Kim1, Ji-Sue Baik1

  • 1College of Natural Resources and Life Science, Dong-A University, Busan 604-714, Republic of Korea ; Medi-Farm Industrialization Research Center, Dong-A University, Busan 604-714, Republic of Korea.

Insights

Triptolide (TPL) triggers apoptosis in human melanoma cells via both extrinsic and intrinsic pathways. This natural compound modulates key proteins like Fas, FAK, and caspases, leading to programmed cell death.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Mechanisms

Background:

  • Triptolide (TPL) exhibits anti-cancer properties by inhibiting proliferation and inducing apoptosis.
  • The exact mechanisms of TPL-induced apoptosis in human melanoma remain unclear.

Purpose of the Study:

  • To elucidate the precise molecular mechanisms of Triptolide-induced apoptosis in human melanoma cells.
  • To investigate the roles of extrinsic and intrinsic apoptosis pathways in TPL's cytocidal effects.

Main Methods:

  • Human melanoma cells were treated with TPL.
  • Flow cytometry and Annexin V-FITC assays were used to assess apoptosis.
  • Western blotting and caspase activity assays were performed to analyze protein expression and activation.

Main Results:

  • TPL significantly inhibited melanoma cell growth and induced apoptosis.
  • TPL upregulated Fas and FADD, activated caspase-8, and promoted cytochrome c release, activating caspase-9 and caspase-3.
  • Apoptosis involved FAK dephosphorylation and cleavage, mediated by caspase-8 and caspase-3 via Fas upregulation.
  • TPL induced RIP dissociation from FAK and enhanced RIP/Fas complex formation.

Conclusions:

  • TPL induces apoptosis in human melanoma cells through both extrinsic and intrinsic pathways.
  • Receptor-interacting protein (RIP) plays a crucial role by shuttling between Fas and FAK to mediate TPL-induced apoptosis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K